绿色核医学与放射性诊疗一体化
随着诊断和治疗用放射性药物需求显著增长,预计大量患者将接受新型核医学治疗,可能带来显著环境影响。本文从供应链、生产能源、运输、注射剂量调整、本地与集中生产、核医学检查与其他温室气体排放影像检查的对比及放射性废物处理等方面,总结影响领域与可能的减排措施。
要点
- 核医学诊疗需求增长可能带来显著环境影响。
- 减排措施可覆盖同位素生产、能源、运输及临床注射剂量调整等供应链环节。
- 本地与集中生产、检查方式选择及废物处理需权衡环境影响。
核心结论
- 本文总结可能作为核医学界进一步讨论的基础,可能提高对该领域环境影响的认识,甚至可能促成措施的实施。
研究设计与样本
- 本文为讨论性综述,未报告系统检索范围或样本量。
主要发现
- 诊断和治疗用放射性药物的兴趣显著增长,预计大量患者将需要接受新型核医学治疗,可能产生显著环境影响。
- 影响领域涵盖从医用同位素生产现场、生产所需能源供应、运输到临床使用中注射放射性药物剂量调整的整个供应链。
关键数值与推荐
- 本文汇总并权衡了本地与集中生产的论点、核医学检查与其他温室气体排放医学影像检查的潜在增减,以及放射性药物废物处理的影响。
临床怎么用
- 本文未据此给出具体临床推荐。
局限性
- 本文为讨论性综述,未报告系统检索范围或样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a significantly growing interest in diagnostic and therapeutic radiopharmaceuticals, and it is foreseeable that an unprecedented number of patients will need to be treated with new nuclear medicine therapies. This predicted increase will have potentially significant environmental impacts. In this discussion, we show different areas of impact, as well as possible measures to reduce such impact. These measures may impact areas from the entire supply chain, starting at the production site of medical isotopes, the energy supply needed for production, transportation, and adaption of the injected amounts of radiopharmaceuticals in clinical use. Furthermore, arguments of local versus centralized production, potentially increasing or decreasing nuclear medicine procedures versus other greenhouse gas-emitting medical imaging tests, as well as radiopharmaceutical waste handling implications, are summarized and weighed against the current status. Overall, this summary hopefully serves as a basis for further discussion in the nuclear medicine community, potentially increases awareness of the environmental impact of this exciting medical field, and may even lead to implementation of measures.
引用
- Veit-Haibach P, Herrmann K, Zimmermann R, et al. Green Nuclear Medicine and Radiotheranostics. J Nucl Med. 2025. PMID: 39848763. doi:10.2967/jnumed.124.268928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。